GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Summit Therapeutics PLC (LSE:SUMM) » Definitions » Other Gross PPE

Summit Therapeutics (LSE:SUMM) Other Gross PPE : £7.52 Mil (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Summit Therapeutics Other Gross PPE?

Summit Therapeutics's Other Gross PPE for the quarter that ended in Mar. 2024 was £7.52 Mil.

Summit Therapeutics's quarterly Other Gross PPE declined from Sep. 2023 (£5.36 Mil) to Dec. 2023 (£4.91 Mil) but then increased from Dec. 2023 (£4.91 Mil) to Mar. 2024 (£7.52 Mil).

Summit Therapeutics's annual Other Gross PPE increased from Dec. 2021 (£2.78 Mil) to Dec. 2022 (£4.51 Mil) and increased from Dec. 2022 (£4.51 Mil) to Dec. 2023 (£4.91 Mil).


Summit Therapeutics Other Gross PPE Historical Data

The historical data trend for Summit Therapeutics's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Summit Therapeutics Other Gross PPE Chart

Summit Therapeutics Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.54 1.19 2.78 4.51 4.91

Summit Therapeutics Quarterly Data
Apr19 Jul19 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.58 5.72 5.36 4.91 7.52

Summit Therapeutics Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Summit Therapeutics (LSE:SUMM) Business Description

Traded in Other Exchanges
Address
2882 Sand Hill Road, Suite 106, Menlo Park, CA, USA, 94025
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its lead CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

Summit Therapeutics (LSE:SUMM) Headlines

No Headlines